Login to Your Account

Clovis Oncology Takes Flight with $145M in VC Funds

By Donna Young

Friday, May 22, 2009
Patrick Mahaffy and his former management team from Pharmion Corp., which was acquired last year for $2.9 billion by Celgene Corp., proved to be a safe bet for their early venture capitalist investors. Indeed, the VCs who had backed Pharmion when it was founded in 2000 returned to support Mahaffy again - this time with a substantial start-up package of $145 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription